Public disclosures
Page built 2026-09-29
Data as of 2026-09-29
Search

Novo Nordisk A/S ADR (NVO): Congress and insider trades

Who in Congress and inside the company traded NVO, when each filing appeared, and what buying after each one would have earned against the S&P 500.

Key Facts

  • Novo Nordisk A/S ADR (NVO) is a listed stock on NYSE.
  • 5 members of Congress filed 11 buys and 5 sells of NVO, the latest published 2026-09-18 (18 September 2026).
  • Across 8 scored buys, Congress averaged +5.4% against the S&P 500 (SPY) over the 90 days after disclosure, with 75% of them ahead of the index. That result is too few trades to draw a conclusion.
  • Data as of 2026-09-29 (29 September 2026).
Congress buys 11 5 members
Congress sells 5
Insider buys 0 $0
Insider sells 0 $0
Congress buys vs S&P, 90d +5.4% 8 scored buys
Insider buys vs S&P, 90d n/a 0 scored buys

Congress trades in NVO

as of 2026-09-18
  1. Ro Khanna11 trades
  2. Daniel S. Goldman2 trades
  3. Katherine Clark2 trades
  4. Alan Armstrong1 trade
  5. Scott Franklin1 trade
Congress trades in NVO, newest first.
FiledMemberTypeSizeDays to file90 day vs S&P
18 Sep 2026 Scott Franklin (R-FL) buy 1K–15K 22 n/a
21 Jul 2026 Alan Armstrong (R-OK) buy 15K–50K 113 n/a
9 Apr 2026 Ro Khanna (D-CA) buy 1K–15K 25 +19.4%
12 Mar 2026 Ro Khanna (D-CA) buy 1K–15K 24 +8.4%
9 Oct 2023 Ro Khanna (D-CA) buy 1K–15K 28 +4.7%
14 Aug 2023 Daniel S. Goldman (D-NY) sell 250K–500K 34 n/a
14 Aug 2023 Daniel S. Goldman (D-NY) sell 100K–250K 32 n/a
14 Jun 2023 Ro Khanna (D-CA) buy 1K–15K 31 +17.8%
10 May 2023 Ro Khanna (D-CA) buy 1K–15K 24 +2.4%
12 Apr 2023 Ro Khanna (D-CA) sell 1K–15K 28 n/a
10 Mar 2023 Ro Khanna (D-CA) buy 15K–50K 26 +1.4%
4 Jan 2023 Ro Khanna (D-CA) sell 1K–15K 29 n/a
17 Nov 2022 Ro Khanna (D-CA) sell 1K–15K 21 n/a
15 Jun 2022 Ro Khanna (D-CA) buy 1K–15K 15 -8.2%
12 May 2022 Ro Khanna (D-CA) buy 1K–15K 16 -2.4%
15 Oct 2021 Katherine Clark (D-MA) exchange 1K–15K 28 n/a
29 Dec 2020 Katherine Clark (D-MA) buy 1K–15K 53 n/a

Frequently asked questions

Who has bought NVO?

11 Congress buys by 5 members and 0 insider buys are on file. The tables on this page list every one.

Did buying NVO after a disclosure beat the market?

Across 8 scored buys, Congress averaged +5.4% against the S&P 500 (SPY) over the 90 days after disclosure, with 75% of them ahead of the index. That result is too few trades to draw a conclusion. A single stock is a small sample.

Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.

Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.